Treatment With Infliximab in a Medical Setting (Study P05587)

Clinical trial NCT00752622 · TERMINATED

Trial details

NCT number: NCT00752622
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2008-11-01
Primary completion: 2010-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.